Stay updated with breaking news from Nasdaq Ptct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $25.49, but opened at $27.00. PTC Therapeutics shares last traded at $27.60, with a volume of 86,284 shares. The biopharmaceutical company reported ($1.20) earnings per share (EPS) […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CEO Matthew B. Klein sold 3,361 shares of the stock in a transaction that occurred on Friday, April 19th. The stock was sold at an average price of $24.89, for a total value of $83,655.29. Following the transaction, the chief executive officer now owns 225,807 shares in […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CEO Eric Pauwels sold 787 shares of PTC Therapeutics stock in a transaction dated Wednesday, April 17th. The stock was sold at an average price of $25.14, for a total value of $19,785.18. Following the transaction, the chief executive officer now owns 67,694 shares in the company, […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CEO Matthew B. Klein sold 3,361 shares of the stock in a transaction dated Friday, April 19th. The shares were sold at an average price of $24.89, for a total transaction of $83,655.29. Following the completion of the transaction, the chief executive officer now directly owns 225,807 […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s share price gapped down before the market opened on Friday . The stock had previously closed at $24.69, but opened at $24.01. PTC Therapeutics shares last traded at $24.98, with a volume of 66,571 shares trading hands. Analysts Set New Price Targets Several equities research analysts have […]